Meeting
2015 ASCO Annual Meeting
Clinical and molecular characteristics of NF1 mutant lung cancer.
Authors
Amanda J. Redig
Dana-Farber Cancer Inst, Boston, MA
Amanda J. Redig , Stacy L. Mach , Marzia Capelletti , Caitlin Fontes , Yunling Shi , Poornima Chalasani , Suzanne Eleanor Dahlberg , Pasi A. Janne
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 33, 2015 (suppl; abstr 8022)
DOI
10.1200/jco.2015.33.15_suppl.8022
Abstract #
8022
Poster Bd #
344
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Molecular characterization of NF1-mutated NSCLC and clinical outcomes.
First Author: Christopher Gates
Poster
2016 ASCO Annual Meeting
Genetic heterogeneity of KRAS-mutated NSCLC: Co-occurrence of potentially targetable aberrations and evolutionary background.
First Author: Matthias Scheffler
Poster
2014 Gastrointestinal Cancers Symposium
Next-generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA).
First Author: Rachna T. Shroff
Poster
2023 ASCO Annual Meeting
Response to neoadjuvant immune checkpoint inhibitor (ICI)-based therapy in oncogene-driven resectable non-small cell lung cancer (NSCLC).
First Author: Samuel Rosner